Part, Chapter, Paragraph
1 I, 2. 10. 4 | interoperability and compatibility. End users are not locked into proprietary
2 II, 5. 4. 1 | adequate information for end users is fundamental to empower
3 II, 5. 5.Int | health care and are the main users of inpatient care11,12.
4 II, 5. 5.Int | has been developed to help Users, Carers and families touched
5 II, 5. 6. 6 | complementary medicine. Users and practitioners of complementary
6 II, 5. 11. 6 | evaluation should begin with the users’ perspective in mind. These
7 II, 6.Acr | Virus~IDU~Injecting Drug Users~LGV~Lymphogranuloma Venereum~
8 II, 6. 3. 3 | HIV among injecting drug users (IDU) accounts for a low
9 II, 6. 3. 4 | homeless, prisoners and drug users.~ ~TB is more common in
10 II, 7.Acr | Rate~VRU~Vulnerable Road Users~VIP~Violence and Injury
11 II, 7. 3. 4 | 1.7 million injured road users according to police records
12 II, 7. 3. 4 | fatalities and injured road users~ ~More than half of road
13 II, 7. 3. 4 | cars but vulnerable road users (pedestrians, cyclists and
14 II, 7. 3. 4 | share of vulnerable road users in these absolute figures
15 II, 7. 4 | disabled;~· Vulnerable road users;~· Sports injuries;~· Injuries
16 II, 7. 4. 3 | Safety of vulnerable road users~ ~Road transport injuries
17 II, 7. 4. 3 | Approximately 17 300 vulnerable road users (VRUs: pedestrians, cyclists
18 II, 7. 4. 3 | pedestrians, 37% to motorised road users and 17% to cyclists. Approximately
19 II, 7. 4. 3 | million vulnerable road users were injured whereof 1.3
20 II, 7. 4. 3 | Mortality of Vulnerable Road Users by road users, EU25~ ~The
21 II, 7. 4. 3 | Vulnerable Road Users by road users, EU25~ ~The data presented
22 II, 7. 4. 3 | injuries to eulnerable road users in the EU which aims at
23 II, 7. 4. 3 | safety of vulnerable road users (pedestrians and two-wheelers)
24 II, 7. 5 | disabilities; vulnerable road users; sport injuries; injuries
25 II, 7. 5 | people, vulnerable road users, sport injuries, products
26 II, 7. 5 | format and supported by a users' manual (WHO, 2005b).~ ~
27 II, 7. 6 | safety of vulnerable road users, and sport safety. Ther
28 II, 7. 7 | Injuries to Vulnerable Road Users Including Falls in Pedestrians
29 II, 7. 7 | WHO) (2005b): TEACH-VIP users’ manual. Geneva, World Health
30 II, 9. 2. 3 | foreign-born and intravenous drug users. It is also thought that
31 II, 9. 3. 1 | healthcare and are the principal users of inpatient care. (Austbury,
32 II, 9. 3. 1 | recently, intravenous drug users (IDUs) with an HIV co-infection.~ ~
33 II, 9. 3. 1 | amongst intravenous drug users, while a growing proportion
34 II, 9. 3. 1 | Atlas~IDUs~Injecting drug users~LOH~Late Onset Hypogonadism~
35 II, 9. 5. 3 | healthcare, and are the main users of inpatient care. Gender
36 II, 9. 5. 3 | About nine out of 10 tobacco users start before they are 18
37 III, 10. 2. 1 | nicotine reported by many users is probably associated to
38 III, 10. 2. 1 | pancreatic cancer in snus users (Luo et al, 2007). Other
39 III, 10. 2. 1 | the gateway effect – snuff users may later become smokers -
40 III, 10. 2. 1 | Virus~IDU~Injecting Drug Users~NSP~Needle and Syringe Programs~
41 III, 10. 2. 1 | of long term problem drug users should also be taken into
42 III, 10. 2. 1 | and mortality among drug users; (v) demand for drug treatment),
43 III, 10. 2. 1 | prevalence and total numbers of users of different drugs in the
44 III, 10. 2. 1 | lifetime are not current users anymore. However, last year
45 III, 10. 2. 1 | the proportion of cannabis users that go on to more intensive
46 III, 10. 2. 1 | or almost daily' cannabis users.~ ~Problem drug use~ ~General
47 III, 10. 2. 1 | consisting of problem drug users (PDUs), treatment demands
48 III, 10. 2. 1 | In total, problem drug users estimates from different
49 III, 10. 2. 1 | include only injecting drug users (IDUs) and problem opioids
50 III, 10. 2. 1 | IDUs) and problem opioids users (POUs), due to various reasons (
51 III, 10. 2. 1 | amphetamines/methamphetamines users ranging from 1.5–5.3 cases
52 III, 10. 2. 1 | estimate of problem cocaine users in the range of 3 to 6 per
53 III, 10. 2. 1 | 15–64.~ ~Problem opioid users and injecting drug users
54 III, 10. 2. 1 | users and injecting drug users still remain the main problem
55 III, 10. 2. 1 | prevalence of problem opioid users at national level range
56 III, 10. 2. 1 | million) problem opioid users in the EU and Norway. Data
57 III, 10. 2. 1 | infectious diseases among drug users. While EU Member States
58 III, 10. 2. 1 | including problem opioid users. These general trends were,
59 III, 10. 2. 1 | homogenous population of opioid users has been replaced by a more
60 III, 10. 2. 1 | including: ageing opioid users who also often use cocaine
61 III, 10. 2. 1 | substances, marginalized crack users, socially integrated problem
62 III, 10. 2. 1 | cocaine and other stimulant users, intensive cannabis users,
63 III, 10. 2. 1 | users, intensive cannabis users, etc. Almost all of these
64 III, 10. 2. 1 | of HIV in injecting drug users (IDUs) continued in several
65 III, 10. 2. 1 | of IDUs and problem drug users it has been estimated that,
66 III, 10. 2. 1 | prevalence among injecting drug users – studies with national
67 III, 10. 2. 1 | 2005, all injecting drug users~ ~In recent years, the predominance
68 III, 10. 2. 1 | infections among injecting drug users is very widespread with
69 III, 10. 2. 1 | of IDUs and problem drug users lead to an estimate of around
70 III, 10. 2. 1 | prevalence among injecting drug users, 2004-2005, all injecting
71 III, 10. 2. 1 | 2005, all injecting drug users~ ~Among the other infections
72 III, 10. 2. 1 | Mortality among drug users12~ ~A multi-country study
73 III, 10. 2. 1 | that mortality among drug users is 6-20 times higher for
74 III, 10. 2. 1(12)| on the mortality of drug users comes from cohort studies,
75 III, 10. 2. 1(12)| generalizable to all problem drug users in the country.~
76 III, 10. 2. 1 | long time, particularly in users with predisposing conditions
77 III, 10. 2. 1 | doubled. European data on drug users entering treatment for primary
78 III, 10. 2. 1 | school drop-outs, cannabis users) and different settings (
79 III, 10. 2. 1 | hepatitis B and C) among drug users have triggered the development
80 III, 10. 2. 1 | at least 580 000 opioid users received drug substitution
81 III, 10. 2. 1 | to about 50% of opiate users undergoing such treatment.
82 III, 10. 2. 1 | helping former problem drug users to access a job and a home,
83 III, 10. 2. 1 | predominantly injectors and opiate users, on the one hand and the
84 III, 10. 2. 1 | among many groups of drug users and problem drug users in
85 III, 10. 2. 1 | drug users and problem drug users in Europe. Poly–drug use
86 III, 10. 2. 1 | population of problem drug users presents multiple health
87 III, 10. 2. 1 | in helping problem drug users or regarding the accessibility
88 III, 10. 2. 1 | risk behaviours among drug users, long-term treatment outcomes
89 III, 10. 2. 1 | Mortality among problem drug users in Europe: a project of
90 III, 10. 2. 1 | and non-injecting cocaine users in Sydney, Australia. Addiction,
91 III, 10. 3. 1 | brain tumours in long-term users, with the exception of acoustic
92 III, 10. 3. 2 | involvement of downstream users; and better risk communication
93 III, 10. 3. 2 | involve both downstream users and producers for reducing
94 III, 10. 4. 2 | the health of consumers, users and of the environment is
95 III, 10. 5. 1 | be twofold, with regular users showing higher survival
96 IV, 11. 2. 1 | have significantly higher users of outpatient care than
97 IV, 11. 6. 2 | introduced to verify the users of health services had paid
98 IV, 11. 6. 2 | informal payments among service users highlight the severity of
99 IV, 12. 10 | First Time Noticed Drug Users: FreD” – aimed to discourage
100 IV, 12. 10 | networking platform of (ex-)users of illegal drugs in co-operation
101 IV, 12. 10 | Interim National Services Users Executive)~ ~Introduction
102 IV, 12. 10 | reducing risks for drugs users~2007: inside prevention
103 IV, 12. 10 | awareness training for drugs users~ Permanent campaign of French
